Publicly-traded biotechnology firm that markets products in oncology. In 2002, IMCL made international headlines following the firm’s founder and CEO Sam Waksal was incriminated for insider trading. Briefly after Waksal’s indictment, domestic diva Martha Stewart was also charged of insider trading. Stewart obtained the details from Waksal and her own broker, stating Waksal tried to discard $5 million worth of his shares in the firm on insider information. Stewart traded her shares on data Wasakal attempted to sell his.